×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| FDC LTD. | 6778.67 | 1221.91 | 6422.81 | 7.51 | 7,444 | 27.7 |
| Thyrocare Technologies Limited | 1828.5 | 360.5 | 1788.9 | 6.78 | 7005 | 65.8 |
| KOVAI MEDICAL CENTER & HOSPITA | NA | NA | NA | NA | 6900 | 119.0 |
FDC Ltd., with Security Code 531599, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 431.2 | 530.0 | 479.7 | 452.2 | 454.2 | 624.1 | 505.1 | 458.9 | 482.0 | 642.3 |
| Expenses | 377.3 | 410.0 | 401.0 | 370.3 | 396.4 | 482.4 | 432.7 | 412.9 | 429.1 | 500.9 |
| Operating Profit | 53.9 | 120.0 | 78.7 | 81.9 | 57.8 | 141.7 | 72.4 | 45.9 | 52.9 | 141.3 |
| OPM % | 12.49% | 22.64% | 16.41% | 18.11% | 12.73% | 22.7% | 14.33% | 10.01% | 10.98% | 22.01% |
| Other Income | 10.1 | 29.8 | 27.4 | 25.3 | 20.7 | 28.2 | 34.7 | 18.6 | 31.4 | 35.6 |
| Interest | 1.1 | 1.0 | 1.1 | 1.0 | 0.9 | 1.3 | 1.1 | 0.9 | 1.2 | 1.2 |
| Depreciation | 9.7 | 9.6 | 9.8 | 9.9 | 10.4 | 11.0 | 13.8 | 13.3 | 15.5 | 14.9 |
| Profit before tax | 53.2 | 139.2 | 95.2 | 96.3 | 67.2 | 157.6 | 92.3 | 50.3 | 67.6 | 160.9 |
| Tax % | -30% | -22% | -24.4% | -18.6% | -28.3% | -27% | -19.8% | 27.6% | -28.6% | 24.1% |
| Net Profit | 37.2 | 108.6 | 72.0 | 78.4 | 48.2 | 115.0 | 74.0 | 36.4 | 48.2 | 122.2 |
| EPS in Rs | 2.24 | 6.54 | 4.36 | 4.81 | 2.97 | 7.06 | 4.55 | 2.24 | 0 | 7.51 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 409.3 | 434.8 | 536.4 | 486.4 | 458.2 | 462.0 | 638.3 | 513.8 | 464.1 | 491.9 |
| Expenses | 360.1 | 385.9 | 414.4 | 409.9 | 374.4 | 405.7 | 491.7 | 443.7 | 417.5 | 437.8 |
| Operating Profit | 49.2 | 49.0 | 122.0 | 76.4 | 83.8 | 56.3 | 146.6 | 70.2 | 46.7 | 54.0 |
| OPM % | 12.03% | 11.26% | 22.75% | 15.71% | 18.29% | 12.19% | 22.97% | 13.65% | 10.05% | 10.99% |
| Other Income | 18.4 | 7.1 | 29.4 | 27.2 | 24.7 | 20.3 | 28.4 | 34.7 | 18.8 | 16.1 |
| Interest | 1.2 | 1.2 | 1.0 | 1.1 | 1.0 | 1.0 | 1.3 | 1.1 | 0.9 | 1.2 |
| Depreciation | 9.9 | 9.7 | 9.6 | 9.9 | 10.0 | 10.4 | 11.0 | 13.8 | 13.4 | 15.6 |
| Profit before tax | 56.6 | 45.1 | 140.7 | 92.7 | 97.5 | 65.2 | 162.7 | 90.0 | 51.2 | 53.4 |
| Tax % | -28.1% | -32% | -22% | -24.7% | -18.8% | -29% | 26.9% | 20% | -27.6% | -27.4% |
| Net Profit | 40.7 | 30.7 | 109.8 | 69.8 | 79.2 | 46.3 | 119.0 | 72.0 | 37.0 | 38.7 |
| EPS in Rs | 2.45 | 1.85 | 6.62 | 4.22 | 4.86 | 2.84 | 7.31 | 0 | 2.28 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 12% |
| 3 Years: | 13% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 11% |
| 3 Years: | 2% |
| TTM: | -8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 14% |
| 3 Years: | 24% |
| 1 Year: | -2% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 12% |
| 3 Years: | 13% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 11% |
| 3 Years: | 1% |
| TTM: | -5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 14% |
| 3 Years: | 24% |
| 1 Year: | -2% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|